Mesa Laboratories Inc. logo

Mesa Laboratories Inc.

MLAB | NASDAQ
Chart Builder DCF Calculator
$135.19
+$3.32 (+2.52%)
Sep 22, 2026, 1:48 PM ET · Market open
TTM
Period Ending
Q1 2027
Jun 29, 2026
Q4 2026
Mar 30, 2026
Q3 2026
Dec 30, 2025
Q2 2026
Sep 29, 2025
Q1 2026
Jun 29, 2025
Q4 2025
Mar 30, 2025
Q3 2025
Dec 30, 2024
Q2 2025
Sep 29, 2024
Q1 2025
Jun 29, 2024
Q4 2024
Mar 30, 2024
Q3 2024
Dec 30, 2023
Q2 2024
Sep 29, 2023
Q1 2024
Jun 29, 2023
Q4 2023
Mar 30, 2023
Q3 2023
Dec 30, 2022
Q2 2023
Sep 29, 2022
Q1 2023
Jun 29, 2022
Q4 2022
Mar 30, 2022
Q3 2022
Dec 30, 2021
Q2 2022
Sep 29, 2021
Q1 2022
Jun 29, 2021
Revenue
249.73M 249.13M 247.54M 245.26M 242.35M 240.98M 237.75M 228.38M 223.71M 216.19M 212.87M 213.69M 219.27M 219.08M 222.37M 222.78M 199.87M 184.34M 163.42M 142.9M 138.92M
Cost of Revenue
84.94M 90.86M 97.51M 97.26M 96.24M 90.11M 88.73M 85.72M 84.4M 82.94M 82.98M 84.43M 85.74M 85.39M 86.76M 91.31M 81.65M 75.25M 64.71M 52.16M 50.03M
Gross Profit
164.79M 158.27M 150.03M 147.99M 146.12M 150.87M 149.01M 142.66M 139.32M 133.25M 129.9M 129.26M 133.54M 133.69M 135.6M 131.47M 118.22M 109.09M 98.71M 90.74M 88.89M
Operating Income
22.48M 18.51M 17.23M 15.04M 13.82M 16.34M -256.42M -262.26M -265.83M -272.08M -274K 3.2M 7.25M 3.32M 2.69M -3.22M -3.02M 4.7M 9.11M 11.64M 11.91M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 107K 107K 107K
Pretax Income
9.36M 12.01M 14.07M 7.26M 9.07M 5.96M -269.83M -265.67M -270.81M -275.65M -593K -623K 4.09M -389K -158K -4.42M -3.26M 3.57M 8.51M 5.13M 2.97M
Net Income
4.8M 6.71M 3.73M -1.57M -620K -1.97M -249.44M -245.65M -250.31M -254.25M 948K -717K 1.82M 930K -1.47M -3.98M -1.56M 1.87M 7.58M 5.09M 4.05M
Selling & General & Admin
107.94M 119.45M 117.09M 117.22M 116.97M 115.02M 111.27M 111.53M 111.39M 111.49M 111.07M 106.46M 106.68M 109.88M 112.25M 113.66M 102.58M 88.62M 76.25M 68.21M 66.28M
Research & Development
20.05M 20.31M 20.16M 20.18M 19.77M 19.52M 19.62M 18.87M 19.22M 19.3M 19.1M 19.61M 19.6M 20.49M 20.67M 21.03M 18.66M 15.77M 13.26M 10.8M 10.6M
Other Expenses
14.32M n/a -4.45M -4.45M -4.45M n/a 274.53M 274.53M 274.53M 274.53M n/a n/a n/a n/a n/a n/a n/a n/a 91K 91K 91K
Operating Expenses
142.31M 139.76M 132.8M 132.96M 132.3M 134.53M 405.43M 404.93M 405.15M 405.33M 130.17M 126.06M 126.29M 130.37M 132.91M 134.69M 121.24M 104.39M 89.61M 79.1M 76.97M
Interest Expense
10.86M 10.69M 10.62M 10.42M 10.58M 11.22M 10.59M 9.6M 7.49M 5.7M 5.19M 4.5M 4.8M 4.77M 4.63M 4.48M 4.09M 3.95M 4.93M 5.86M 6.98M
Selling & Marketing Expenses
29.86M 40.79M 41.98M 42.45M 42.5M 41.68M 40.68M 39.96M 39.77M 38.63M 38.14M 36.84M 36.39M 37.44M 37.51M 38.03M 33.48M 28.31M 24.33M 20.12M 19.26M
Cost & Expenses
227.25M 230.62M 230.31M 230.22M 228.53M 224.64M 494.16M 490.64M 489.54M 488.26M 213.15M 210.49M 212.02M 215.76M 219.68M 226M 202.88M 179.63M 154.31M 131.25M 127.01M
Income Tax Expense
4.56M 5.3M 10.33M 8.83M 9.69M 7.94M -20.39M -20.02M -20.5M -21.4M -1.54M 94K 2.27M -1.32M 1.31M -439K -1.69M 1.7M 937K 33K -1.09M
Shares Outstanding (Basic)
5.66M 5.54M 5.53M 5.51M 5.47M 5.43M 5.43M 5.41M 5.4M 5.39M 5.39M 5.39M 5.37M 5.35M 5.34M 5.32M 5.27M 5.25M 5.23M 5.21M 5.15M
Shares Outstanding (Diluted)
5.76M 5.54M 5.57M 5.54M 5.55M 5.43M 5.43M 5.47M 5.42M 5.39M 5.4M 5.39M 5.37M 5.38M 5.36M 5.36M 5.27M 5.25M 5.23M 5.34M 5.3M
EPS (Basic)
0.86 1.23 0.67 -0.30 -0.12 -0.36 -46.25 -45.55 -46.41 -47.14 0.17 -0.14 0.34 0.17 -0.28 -0.75 -0.29 0.37 1.47 0.97 0.78
EPS (Diluted)
0.84 1.20 0.64 -0.32 -0.14 -0.37 -46.26 -45.56 -46.42 -47.14 0.17 -0.14 0.33 0.16 -0.29 -0.76 -0.30 0.35 1.43 0.93 0.74
EBITDA
40.58M 43.38M 49.7M 42.48M 44.66M 41.71M -235.92M -229.19M -234.41M -238.38M 38.93M 37.74M 42.71M 38.21M 38.62M 32.48M 29.46M 32.59M 33.85M 29.16M 28.27M
EBIT
17.62M 20.11M 24.68M 17.68M 19.65M 17.18M -259.24M -256.07M -263.32M -269.95M 4.6M 3.87M 8.89M 4.38M 4.47M 69K 829K 7.52M 13.44M 10.99M 9.95M
Depreciation & Amortization
22.96M 23.27M 25.02M 24.8M 25.02M 24.53M 23.33M 26.88M 28.91M 31.57M 34.33M 33.87M 33.82M 33.82M 34.15M 32.41M 28.63M 25.07M 20.41M 18.18M 18.32M

© 2026 bestshares.com. All rights reserved.